Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine combined with different opioid agonist-antagonists for analgesia during percutaneous vertebroplasty in elderly patients
ChiCTR2500095299Phase 4Recruiting
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Jan 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, butorphanol, nalbuphine and pentazocine in vertebral compression fracture (VCF) (4 arms), sponsored by Dalian Municipal Central Hospital. Primary endpoint: VAS pain scores. Started Jan 2025; status: recruiting.
02
Drugs
dexmedetomidinebutorphanolnalbuphinepentazocine
03
Conditions
vertebral compression fracture (VCF)
Beyond the preview
Go deeper on ChiCTR2500095299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095299.